Skip to main content
Log in

First clinical isolate of highly fluoroquinolone-resistantEscherichia coli in scandanavia

  • Letters
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Bauernfind A, Sauerwein D, Danniger J, Keding M: Reduktion der Empfindlichkeit vonPseudomonas aeruginosa gegenüber neuen 4-Quinolonen durch Mutation in Vitro und in Vivo. Fortschritte der antimikrobiellen und antineoplastischen Chemotherapie 1984, 3: 521–529.

    Google Scholar 

  2. Limb DI, Dabbs DJW, Spancer RC: In vitro selection of bacteria resistant to the 4-quinolone agents. Journal of Antimicrobial Chemotherapy 1987, 19: 65–71.

    PubMed  Google Scholar 

  3. Desplaces N, Gutman L, Carlet J, Guibert J, Acar JF: The new quinolones and their combinations with other agents for therapy of severe infections. Journal of Antimicrobial Chemotherapy 1986, 17; Supplement A: 25–39.

    PubMed  Google Scholar 

  4. Bairley RR, Peddie BA, Blake E: Norfloxacin for the treatment of uncomplicated urinary tract infections. New Zealand Medical Journal 1983, 96: 476.

    PubMed  Google Scholar 

  5. Sato K, Inone Y, Fujii T, Aoyama H, Inone M, Mitsuhashi M: Purification and properties of DNA gyrase from a fluoroquinolone-resistant strain of Escherichia coli. Antimicrobial Agents and Chemotherapy 1986, 30: 777–780.

    PubMed  Google Scholar 

  6. Aoyama H, Sato K, Kato K, Hirai K, Mitsuhashi S: Norfloxacin resistance in a clinical isolate ofEscherichia coli. Antimicrobial Agents and Chemotherapy 1987, 31: 1640–1641.

    PubMed  Google Scholar 

  7. Lewin CS, Smith JT, Hamilton-Miller JMT, Brumfitt W: Gain of antibioticsenstivity accompanying emergence of clinical ciprofloxacin resistance. Lancet 1988, i: 1462–1463.

    Google Scholar 

  8. Aubert G, Puech C, Lucht F, Loboguerrero M, Denis M, Dorche G: Activité de cinq fluoroquinolones sur les bacilles à gram négatif hospitaliers de différentes sensibilités à la péfloxacine. Pathologie Biologie 1989, 8: 881–887.

    Google Scholar 

  9. Lopez-Brea M, Alarcón T: Isolation of fluoroquinolone-resistantEscherichia coli andKlebsiella pneumonia from an infected Hickman catheter. European Journal of Clinical Microbiology and Infectious Diseases 1990, 9: 345–346.

    Google Scholar 

  10. Watanabe M, Kotera Y, Yosue K, Inoue M, Mitsuhashi S: In vitro emergence of quinolone-resistant mutants ofEscherichia coli, Enterobacter cloacae, andSerratia marcescens. Antimicrobial Agents and Chemotherapy 1990, 34: 173–175.

    PubMed  Google Scholar 

  11. Fisher LM, Lawrence JM, Josty IC, Hopewell R, Margerrison EEC, Cullen ME: Ciprofloxacin and fluoroquinolones. American Journal of Medicine 1989, 87, Supplement 5A: 8.

    Google Scholar 

  12. Cullen ME, Wyke AW, Kuroda R, Fisher LM: Cloning and characterization of a DNA gyrase A gene fromEscherichia coli that confers clinical resistance to 4-quinolones. Antimicrobial Agents and Chemotherapy 1989, 33: 886–894.

    PubMed  Google Scholar 

  13. Hooper DC, Wolfson JS, Sonza KS, Tung C, McHugh GL, Skartz MN: Genetic and biochemical characterization of norfloxacin resistance inEscherichia coli. Antimicrobial Agents and Chemotherapy 1986, 29: 639–644.

    PubMed  Google Scholar 

  14. Hirai K, Aoyama H, Suzue S, Irikura T, Iyobe S, Mitsuhashi S: Isolation and characterization of norfloxacin-resistant mutants ofEscherichia coli K-12. Antimicrobial Agents and Chemotherapy 1986, 30: 248–253.

    PubMed  Google Scholar 

  15. Cohen SP, McMurray LM, Hooper DC, Wolfson JS, Levy SB: Cross-resistance to fluoroquinolones in multipleantibiotic-resistant (MAR)Escherichia coli selected by tetracycline or chloramphenicol: decreased drug accumulation associated with membrane changes in addition to OmpF reduction. Antimicrobial Agents and Chemotherapy 1989, 33: 1318–1325.

    PubMed  Google Scholar 

  16. Ronald AR, Turck M, Petersdorf RG: A critical evaluation of nalidixic acid in urinary tract infections. New England Journal of Medicine 1966, 175: 1081–1089.

    Google Scholar 

  17. Lumish RM, Norden CW: Cinoxacin: in vitro antibacterial studies of a new synthetic organic acid. Antimicrobial Agents and Chemotherapy 1975, 7: 159–163.

    PubMed  Google Scholar 

  18. Jonsson M, Englund G, Nörgård K: Norfloxacin versus pivmecillinam in the treatment of uncomplicated lower urinary tract infection in hospitalized elderly patients. Scandinavian Journal of Infectious Diseases 1990, 22: 339–344.

    PubMed  Google Scholar 

  19. Greenwood D, Osman M, Goodwin J, Cowishaw WA, Slack R: Norfloxacin: activity against urinary tract pathogens and factors influencing the emergence of resistance. Journal of Antimicrobial Agents and Chemotherapy 1984, 13: 315–323.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jonsson, M., Walder, M. & Forsgren, A. First clinical isolate of highly fluoroquinolone-resistantEscherichia coli in scandanavia. Eur. J. Clin. Microbiol. Infect. Dis. 9, 851–853 (1990). https://doi.org/10.1007/BF01967392

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01967392

Keywords

Navigation